While sFlt-1 helps regulate VEGF activity to prevent excessive angiogenesis, elevated circulating sFlt-1 levels have been associated with endothelial dysfunction in CKD patients and post-kidney transplantation. Here, VEGFA is linked to chronic kidney disease.